Commentary: PROTACs make undruggable targets druggable: Challenge and opportunity
被引量：6
摘要
Proteostasis(protein homeostasis) ensures precise adjustment of cellular demand to proteins in the stress conditions, which is essential in the maintenance of health environment inside cells and is indispensable for the life of organisms1.
同被引文献61
-
1Jinyi Liu,Liwen Ren,Sha Li,Wan Li,Xiangjin Zheng,Yihui Yang,Weiqi Fu,Jie Yi,Jinhua Wang,Guanhua Du.The biology,function,and applications of exosomes in cancer[J].Acta Pharmaceutica Sinica B,2021,11(9):2783-2797. 被引量：41
-
2Kailin Li,Jieqiong You,Qian Wu,Wen Meng,Qiaojun He,Bo Yang,Chengliang Zhu,Ji Cao.Cyclin-dependent kinases-based synthetic lethality: Evidence, concept, and strategy[J].Acta Pharmaceutica Sinica B,2021,11(9):2738-2748. 被引量：4
-
3Anil Ahsan,Mengru Liu,Yanrong Zheng,Wenping Yan,Ling Pan,Yue Li,Shijia Ma,Xingxian Zhang,Ming Cao,Zhanxun Wu,Weiwei Hu,Zhong Chen,Xiangnan Zhang.Natural compounds modulate the autophagy with potential implication of stroke[J].Acta Pharmaceutica Sinica B,2021,11(7):1708-1720. 被引量：7
-
4Yuanyuan Chen,Zhaojun Li,Xiaoguang Chen,Sen Zhang.Long non-coding RNAs: From disease code to drug role[J].Acta Pharmaceutica Sinica B,2021,11(2):340-354. 被引量：47
-
5Hongxia Duan,Yanhong Liu,Zhonggao Gao,Wei Huang.Recent advances in drug delivery systems for targeting cancer stem cells[J].Acta Pharmaceutica Sinica B,2021,11(1):55-70. 被引量：23
-
6Kai Yuan,Xiao Wang,Haojie Dong,Wenjian Min,Haiping Hao,Peng Yang.Selective inhibition of CDK4/6: A safe and effective strategy for developing anticancer drugs[J].Acta Pharmaceutica Sinica B,2021,11(1):30-54. 被引量：8
-
7Nitin Bharat Charbe,Nikhil D.Amnerkar,B.Ramesh,Murtaza M.Tambuwala,Hamid A.Bakshi,Alaa A.A.Aljabali,Saurabh C.Khadse,Rajendran Satheeshkumar,Saurabh Satija,Meenu Metha,Dinesh Kumar Chellappan,Garima Shrivastava,Gaurav Gupta,Poonam Negi,Kamal Dua,Flavia C.Zacconin.Small interfering RNA for cancer treatment:overcoming hurdles in delivery[J].Acta Pharmaceutica Sinica B,2020,10(11):2075-2109. 被引量：14
-
8Jin Wang,Hao Zhou.Mitochondrial quality control mechanisms as molecular targets in cardiac ischemia-reperfusion injury[J].Acta Pharmaceutica Sinica B,2020,10(10):1866-1879. 被引量：25
-
9Wei Chen,Yang Hu,Dianwen Ju.Gene therapy for neurodegenerative disorders:advances, insights and prospects[J].Acta Pharmaceutica Sinica B,2020,10(8):1347-1359. 被引量：8
-
10Honggang Xiang,Jifa Zhang,Congcong Lin,Lan Zhang,Bo Liu,Liang Ouyang.Targeting autophagy-related protein kinases for potential therapeutic purpose[J].Acta Pharmaceutica Sinica B,2020,10(4):569-581. 被引量：40
引证文献6
-
1Jiajia Xu,Wei Du,Yunhe Zhao,Kahleong Lim,Li Lu,Chengwu Zhang,Lin Li.Mitochondria targeting drugs for neurodegenerative diseases——Design, mechanism and application[J].Acta Pharmaceutica Sinica B,2022,12(6):2778-2789. 被引量：3
-
2李金秀,董何伟,侯卫.基于PROTAC技术的靶向CDK9小分子降解剂的研究进展[J].药学学报,2022,57(9):2696-2708. 被引量：2
-
3Sinan Ma,Jianai Ji,Yuanyuan Tong,Yuxuan Zhu,Junwei Dou,Xian Zhang,Shicheng Xu,Tianbao Zhu,Xiaoli Xu,Qidong You,Zhengyu Jiang.Non-small molecule PROTACs(NSM-PROTACs):Protein degradation kaleidoscope[J].Acta Pharmaceutica Sinica B,2022,12(7):2990-3005. 被引量：1
-
4Ling Zou,Minru Liao,Yongqi Zhen,Shiou Zhu,Xiya Chen,Jin Zhang,Yue Hao,Bo Liu.Autophagy and beyond:Unraveling the complexity of UNC-51-like kinase 1(ULK1)from biological functions to therapeutic implications[J].Acta Pharmaceutica Sinica B,2022,12(10):3743-3782. 被引量：4
-
5Jing Ye,Jin Zhang,Yanghui Zhu,Lian Wang,Xian Jiang,Bo Liu,Gu He.Targeting autophagy and beyond:Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy[J].Acta Pharmaceutica Sinica B,2023,13(12):4688-4714.
-
6Xiaopeng Peng,Zhihao Hu,Limei Zeng,Meizhu Zhang,Congcong Xu,Benyan Lu,Chengpeng Tao,Weiming Chen,Wen Hou,Kui Cheng,Huichang Bi,Wanyi Pan,Jianjun Chen.Overview of epigenetic degraders based on PROTAC, molecular glue, and hydrophobic tagging technologies[J].Acta Pharmaceutica Sinica B,2024,14(2):533-578.
二级引证文献10
-
1魏一飞,欧阳毅翔,程齐来,郭小华.基于蛋白降解靶向嵌合体技术的分子胶降解剂的研究进展[J].赣南医学院学报,2022,42(11):1202-1208.
-
2牟伊,文帅,王燕,姜正羽.可控性蛋白降解靶向嵌合体(PROTACs)技术研究进展[J].药学学报,2023,58(8):2193-2202.
-
3刘昭祥,刘森.蛋白降解靶向嵌合体临床前及临床研究进展[J].生物工程学报,2023,39(9):3615-3627. 被引量：1
-
4范崇熙,张云水,孙兵兵,王晓莹,赵东林,杨全龙,石学汇,刘磊.紫檀芪保护HT22细胞抗过氧化氢诱导凋亡的机制研究[J].局解手术学杂志,2023,32(10):839-845.
-
5陈祥和,仇啸,刘驰,沈梓铭,周香香.自噬:运动改善神经退行性疾病的关键机制[J].中国比较医学杂志,2023,33(10):132-139.
-
6杨艺璠,宋秀庆,高志明,未朝春,闫红,钟启迪.基于虚拟筛选和分子动力学模拟发现新型ULK1抑制剂[J].化学通报,2024,87(1):92-97. 被引量：1
-
7Yanping Wang,Weihong Du,Xiaoyan Hu,Xin Yu,Chun Guo,Xinchun Jin,Wei Wang.Targeting the blood-brain barrier to delay aging-accompanied neurological diseases by modulating gut microbiota,circadian rhythms,and their interplays[J].Acta Pharmaceutica Sinica B,2023,13(12):4667-4687.
-
8Jing Ye,Jin Zhang,Yanghui Zhu,Lian Wang,Xian Jiang,Bo Liu,Gu He.Targeting autophagy and beyond:Deconvoluting the complexity of Beclin-1 from biological function to cancer therapy[J].Acta Pharmaceutica Sinica B,2023,13(12):4688-4714.
-
9张昊阜子,岳康异,邹鹏,罗鹏,蒋晓帆.Sirtuin 3在中枢神经系统退行性疾病中的研究进展[J].空军军医大学学报,2024,45(4):455-460.
-
10曹秀丽,黄佩,马金花,黄茂林,官亚宁,陈艳,何志旭.激酶ULK1对急性T淋巴细胞白血病细胞凋亡作用的研究[J].遵义医科大学学报,2024,47(4):376-383.
-
1Shanshan Liu,Xiaoxi Lv,Xupeng Wei,Chang Liu,Qiao Li,Jiali Min,Fang Hua,Xiaowei Zhang,Ke Li,Pingping Li,Yang Xiao,Zhuowei Hu,Bing Cui.TRIB3-GSK-3β interaction promotes lung fibrosis and serves as a potential therapeutic target[J].Acta Pharmaceutica Sinica B,2021,11(10):3105-3119. 被引量：2
-
2Yinghua Zhao,Liyan Sui,Ping Wu,Wenfang Wang,Zedong Wang,Yang Yu,Zhijun Hou,Guangyun Tan,Quan Liu,Guoqing Wang.A dual-role of SARS-CoV-2 nucleocapsid protein in regulating innate immune response[J].Signal Transduction and Targeted Therapy,2021,6(10):2995-3008. 被引量：4
-
3Arun Upadhyay.Natural compounds in the regulation of proteostatic pathways: An invincible artillery against stress, ageing, and diseases[J].Acta Pharmaceutica Sinica B,2021,11(10):2995-3014. 被引量：4
-
4Shu Song,Ping Gao,Lin Sun,Dongwei Kang,Jacob Kongsted,Vasanthanathan Poongavanam,Peng Zhan,Xinyong Liu.Recent developments in the medicinal chemistry of single boron atom-containing compounds[J].Acta Pharmaceutica Sinica B,2021,11(10):3035-3059. 被引量：1
-
5李晓蕊,陆梁军,高伟,李鑫,陈建平,周林杰.Silicon non-blocking 4×4 optical switch with automated polarization adjustment[J].Chinese Optics Letters,2021,19(10):38-43.
-
6Xiao-Yan Wang,Jia-Jia Wang,Cheng-Jiang Zhang,Wen-Wei Tong,Bo Jiang,Guang-Xian Lu,Zhi-Xun Wen,Tao Feng.Creep prediction model for nickel-based single-crystal superalloys considering precipitation of TCP phase[J].Rare Metals,2021,40(10):2892-2904. 被引量：2
-
7Shuai-Jin Wu,Zhao-Hui Wu,Sheng Fang,Xiao-Peng Qi,Bing Yu,Juan-Yu Yang.A comparison of core–shell Si/C and embedded structure Si/C composites as negative materials for lithium-ion batteries[J].Rare Metals,2021,40(9):2440-2446. 被引量：2
-
8Ilaria Pagnoni,Elena Gobbi,Enrico Premi,Barbara Borroni,Giuliano Binetti,Maria Cotelli,Rosa Manenti.Language training for oral and written naming impairment in primary progressive aphasia:a review[J].Translational Neurodegeneration,2021,10(3):297-330. 被引量：3
-
9Masahiro Nakamura,Kazusaku Kamiya,Atsushi Furuhata,Katsuhisa Ikeda,Frangois Niyonsaba.S100A7 Co-localization and Up-regulation of Filaggrin in Human Sinonasal Epithelial Cells[J].Current Medical Science,2021,41(5):863-868.
-
10Sunny,Chi Lik Au,Callie,Ka Li Ko.Prevalence of SARS-CoV-2 among central retinal artery occlusion patients:A case series-HORA study report No.3[J].Journal of Acute Disease,2021,10(4):147-149. 被引量：1
